Zhigang Lin

Dr. Zhigang Lin


Research Focus & Metrics

Academic Career Length

4Years (2023-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
27 October 2025
Verified
Conference Paper
Open access
HLHang Lv
Hang Lv
ZGZixuan Guo
Zixuan Guo
ZWZijie Wu
Zijie Wu
YTYanchao Tan
Yanchao Tan
GMGuofang Ma
Guofang Ma
CYCarl Yang
Carl Yang

30 September 2024 in JMIR Research Protocols
Verified
Journal Article
Open access
CJChangzheng Jiang
Changzheng Jiang
HHHongye Huang
Hongye Huang
LCLechun Chen
Lechun Chen
JJJingjing Jiang
Jingjing Jiang
HZHuanzhen Zhang
Huanzhen Zhang
ZLZhigang Lin
Zhigang Lin
Background: Lumbar disc herniation (LDH) has become a serious public health and socioeconomic problem. Tuina is a Chinese medicine treatment method based on meridian acupuncture theory and modern anatomy. Tuina can relieve pain and muscle tension and improve functional disorders; this massage is performed by pressing, kneading, pushing, pulling, and shaking the skin, muscles, and bones. However, the mechanism of action and the effect of Tuina as an external treatment on the activities of the central nervous system to relieve LDH pain is unclear. Therefore, we performed functional magnetic resonance imaging (fMRI), which is widely used in pain-related research, as it can detect the effects of different types of pain on brain activity. Objective: Our randomized controlled parallel-group trial aims to compare the effects of Tuina with those of transcutaneous electrical nerve stimulation (TENS) with traction in patients with LDH. Methods: This trial will be conducted between May 2024 and April 2025 in the Rehabilitation Hospital affiliated to Fujian University of Traditional Chinese Medicine. Seventy-six participants with LDH will be enrolled for this trial and randomly assigned to 2 groups: Tuina intervention group and TENS with traction intervention group. Participants in both groups will receive treatment for 14 days. fMRI will be performed for the main pain measurements by assessing the effect of the intervention on brain activity before and after the end of the intervention. Short-Form McGill Pain Questionnaire, pressure pain thresholds, and the Oswestry disability index will be used to reflect the degree of pain and lumbar dysfunction, and the results will be used as secondary outcome measurements. Results: The study protocol has been approved by the ethics review committee of The Rehabilitation Hospital affiliated to Fujian University of Traditional Chinese Medicine. This study was registered on May 1, 2024, with the Chinese Clinical Trial Registry. Data collection began on May 2024 and is expected to end on April 2025. Currently, data from this trial are in the collection phase, and no data analysis has been performed. As of July 1, 2024, we have collected data from 21 patients. The results of this trial are expected to be submitted for publication in September 2025. Conclusions: This clinical trial will compare the effectiveness of Tuina with that of TENS with traction in the treatment of patients with LDH and will show the cerebral mechanism of Tuina in LDH treatment by using fMRI. The results of our trial will be helpful in clarifying the cerebral mechanism of Tuina in the treatment of LDH and provide a solid foundation for Tuina therapy research. Trial Registration: Chinese Clinical Trial Registry ChiCTR2400083784; https://www.chictr.org.cn/showproj.html?proj=225157 International Registered Report Identifier (IRRID): DERR1-10.2196/63852

10 September 2024 in BMJ Open
Verified
Journal Article
Open access
PDF file
JCJincheng Chen
Jincheng Chen
ZLZhigang Lin
Zhigang Lin
SCShuijin Chen
Shuijin Chen
JHJian He
Jian He
WLWeilin Liu
Weilin Liu
SYShanli Yang
Shanli Yang
Introduction Poststroke shoulder pain is a common complication that severely affects the recovery of upper limb motor function. Acupuncture has positive analgesic effects in treating poststroke shoulder pain, and studies have demonstrated the efficacy of transcranial direct current stimulation (tDCS) in treating patients with this pain. However, whether acupuncture combined with tDCS has a superior rehabilitation effect on poststroke shoulder pain is currently unknown. We aimed to observe the effect of the combined intervention on poststroke shoulder pain and explore its possible central analgesic mechanism. Methods and analysis This study describes a randomised controlled trial using assessor blinding. A total of 135 poststroke patients with shoulder pain will be randomly assigned in a 1:1:1 ratio to the tDCS group, acupuncture group and combined group (acupuncture plus tDCS). All three groups will undergo conventional rehabilitation treatment. Participants in the tDCS group will receive tDCS stimulation on the M1 area for 20 min, while the acupuncture group will receive 20 min of acupuncture. The combined treatment group will receive both. All treatments will be performed five times per week for 4 weeks. The primary outcome indicator in this study is the Visual Analogue Scale pain score. Secondary outcome indicators include shoulder mobility, Shoulder Pain and Disability Index, Fugl–Meyer Motor Function Scale, Modified Barthel Index Scale, Self-Rating Anxiety and Depression Scale and functional MRI. All scale results will be assessed at baseline and at 2 weeks and 4 weeks, and during follow-up at 1 month, 3 months and 6 months postdischarge. A repeated analysis of variance will be conducted to observe the group×time interaction effects of the combined intervention. Moreover, functional MRI will be applied to explore the central analgesic mechanism. Ethics and dissemination Ethics approval was obtained from the Ethics Committee of the Affiliated Rehabilitation Hospital of Fujian University of Traditional Chinese Medicine (2023KY-039–001). The results of the study will be published in a peer-reviewed journal and presented at scientific conferences. Trial registration number ChiCTR2300078270.

7 January 2026 in Journal of Cellular and Molecular Medicine
Verified
Journal Article
Open access
HZHuanzhen Zhang
Huanzhen Zhang
LCLechun Chen
Lechun Chen
JJJingjing Jiang
Jingjing Jiang
LHLimei Huang
Limei Huang
HHHongye Huang
Hongye Huang
ZLZhigang Lin
Zhigang Lin
While Tuina has demonstrated clinical efficacy in alleviating neuropathic pain (NP) induced by peripheral nerve injury, the underlying molecular mechanisms remain unclear. Synaptic plasticity in the spinal dorsal horn (SDH) is a key regulator of pain processing, wherein astrocytes play a central role. Regulation of N‐myc downstream‐regulated gene 2 (NDRG2) and glutamate transporter 1 (GLT‐1) is particularly important in NP modulation. Accumulating evidence suggests that Tuina exerts analgesic effects by inhibiting aberrant synaptic plasticity. This study explored whether Tuina regulates synaptic plasticity through astrocytes to attenuate NP. Using an in vivo model, Tuina or the astrocytic inhibitor fluorocitrate was administered to a chronic constriction injury (CCI)‐induced NP rat model for 14 days. Tuina significantly alleviated pain hypersensitivity in CCI rats, improved structural damage, suppressed astrocytic activation, reduced glutamate accumulation and restored the SDH's expression of proteins linked to synaptic plasticity. These effects were associated with inhibition of astrocytic NDRG2 and upregulation of GLT‐1. Conversely, NDRG2 overexpression through AAV impaired Tuina's ability to promote glutamate transport, leading to glutamate accumulation, enhanced excitatory transmission and reduced analgesic efficacy. In conclusion, Tuina alleviates NP by modulating the astrocytic NDRG2/GLT‐1 pathway, reducing synaptic glutamate levels and normalising synaptic plasticity. These findings provide new mechanistic insights into Tuina's analgesic action and have identified NDRG2/GLT‐1 as a possible therapeutic target for NP treatment.

7 May 2026 in Frontiers in Medicine
Verified
Journal Article
Open access
PDF file
SZSiwei Zhou
Siwei Zhou
CJChangzheng Jiang
Changzheng Jiang
QXQiangwen Xie
Qiangwen Xie
BZBang Zhan
Bang Zhan
LLLin Li
Lin Li
ZLZhigang Lin
Zhigang Lin
Background: Chronic Non-Specific Low Back Pain (CNLBP) is a prevalent musculoskeletal condition. Tuina therapy and non-steroidal anti-inflammatory drugs (NSAIDs) are two commonly used treatments for CNLBP, both of which have demonstrated some clinical efficacy. However, the effectiveness, safety, and potential opioid-sparing effects of Tuina, a classic complementary and alternative therapy, have yet to be rigorously validated through clinical research. Objective: This study aims to conduct a randomized controlled superiority trial with an open-label design, blinded assessment, and parallel groups to evaluate the effectiveness, safety, and complementary role of Tuina in the treatment of CNLBP. Study design and methods: This is a single-center, randomized controlled, assessor-blind clinical trial. A total of 80 participants aged 18–60 years meeting the diagnostic criteria for CNLBP will be recruited and randomly assigned to either the experimental group (Tuina combined with Loxoprofen Sodium patches) or the control group (Loxoprofen Sodium patches). The Tuina intervention will be administered three times weekly for four consecutive weeks; Loxoprofen Sodium patches will be used as needed. The primary outcome measure is the Visual Analogue Scale (VAS) for pain after 4 weeks of treatment. Secondary outcomes include the Oswestry Disability Index (ODI), 36-Item Short Form Health Survey (SF-36), Beck Depression Inventory-Second Edition (BDI-II), Beck Anxiety Inventory (BAI), Surface Electromyography (sEMG) and musculoskeletal ultrasound (MSK US) parameters, medication usage, and 12-week follow-up data. Statistical analysis will follow the intention-to-treat (ITT) principle, using SPSS 26.0 for between-group comparisons and repeated measures analysis. Discussion: Through a rigorous randomized controlled design incorporating both physiological and morphological objective indicators, this study aims to provide high-level evidence regarding the analgesic efficacy, safety, and potential for drug dose reduction of Tuina in treating CNLBP. It also seeks to offer clinical evidence and practical references for the application of Tuina in the rehabilitation of musculoskeletal disorders. Clinical trial registration: https://itmctr.ccebtcm.org.cn/mgt/project/user/user-project-view/4621255a-332d-4ba4-b09b-e9412ba06d0b , Identifier (ITMCTR2026000745).

1 March 2026 in Journal of Pain Research
Verified
Journal Article
Open access
PDF file
CJChangzheng Jiang
Changzheng Jiang
HZHuanzhen Zhang
Huanzhen Zhang
XWXiaoyan Wu
Xiaoyan Wu
LHLanting Huang
Lanting Huang
XZXuekun Zhou
Xuekun Zhou
ZLZhigang Lin
Zhigang Lin
Purpose: This study conducted a randomized controlled trial by analyzing resting-state functional magnetic resonance imaging (rs-fMRI) data to determine the mechanisms by which Tuina alleviates pain and modulates multiple brain networks in lumbar disc herniation (LDH) patients. Patients and Methods: This study included 38 healthy subjects and 76 LDH patients. LDH patients were randomly assigned into the test group (TG; n = 38) and control group (CG; n = 38). TG patients received 14 days of Tuina therapy, whereas CG patients received a combination of transcutaneous electrical nerve stimulation (TENS) and lumbar traction therapy. The primary outcome measure, simplified McGill Pain Questionnaire (SF-MPQ), was used to assess pain. Pain pressure threshold (PPT), Oswestry Disability Index (ODI), Beck Depression Inventory II (BDI-II), and Beck Anxiety Inventory (BAI) were evaluated as secondary outcomes. Fractional amplitude of low-frequency fluctuation (fALFF) and functional connectivity (FC) values were evaluated from the rs-fMRI data before and after treatment. Results: The SF-MPQ score significantly decreased in both TG subjects [− 13.00 (− 19.00, − 9.00); P < 0.001] and CG subjects [− 11.00 (− 14.00, − 7.00); P < 0.001]. SF-MPQ scores were significantly different between the two groups (P < 0.05). In TG subjects, Tuina inhibited spontaneous neural activity in the bilateral inferior frontal gyrus triangular part (IFGtri) and suppressed the interaction between IFGtri and other brain regions. Changes in FC between IFGtri.R and STG.pole.R positively correlated with improvements in SF-MPQ scores (r = 0.511, P = 0.005). Changes in FC between IFGtri.L and IFGtri.R negatively correlated with reduced PPT of the bilateral gluteus maximus (r = − 0.518, P = 0.004). Conclusion: Tuina effectively alleviates pain, lumbar dysfunction, and negative emotions in LDH patients by regulating the interactions between multiple neural networks in the brain, especially through the inferior frontal gyrus triangle area.